241 related articles for article (PubMed ID: 38099574)
1. Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma.
Zou DD; Sun YZ; Li XJ; Wu WJ; Xu D; He YT; Qi J; Tu Y; Tang Y; Tu YH; Wang XL; Li X; Lu FY; Huang L; Long H; He L; Li X
Elife; 2023 Dec; 12():. PubMed ID: 38099574
[TBL] [Abstract][Full Text] [Related]
2. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
[TBL] [Abstract][Full Text] [Related]
3. Loss of retinoic acid receptor-related receptor alpha (Rorα) promotes the progression of UV-induced cSCC.
Zhang G; Yan G; Fu Z; Wu Y; Wu F; Zheng Z; Fang S; Gao Y; Bao X; Liu Y; Wang X; Zhu S
Cell Death Dis; 2021 Mar; 12(3):247. PubMed ID: 33664254
[TBL] [Abstract][Full Text] [Related]
4. Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling.
Lambert SR; Mladkova N; Gulati A; Hamoudi R; Purdie K; Cerio R; Leigh I; Proby C; Harwood CA
Br J Cancer; 2014 Jan; 110(2):520-9. PubMed ID: 24335922
[TBL] [Abstract][Full Text] [Related]
5. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
[TBL] [Abstract][Full Text] [Related]
6. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
Zuo S; Li X; Bao W; Li S
Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic genes related to the progression of actinic keratoses to cutaneous squamous cell carcinoma.
Zhang L; Qin H; Wu Z; Chen W; Zhang G
Int J Dermatol; 2018 Oct; 57(10):1208-1217. PubMed ID: 30105812
[TBL] [Abstract][Full Text] [Related]
8. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
9. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
[TBL] [Abstract][Full Text] [Related]
10. Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
Rymsza A; Świerczyńska K; Piotrowska A; Dzięgiel P; Szepietowski JC
In Vivo; 2022; 36(3):1245-1251. PubMed ID: 35478139
[TBL] [Abstract][Full Text] [Related]
11. Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.
Dańczak-Pazdrowska A; Pazdrowski J; Polańska A; Basta B; Schneider A; Kowalczyk MJ; Golusiński P; Golusiński W; Adamski Z; Żaba R; Masternak MM
Arch Dermatol Res; 2022 Apr; 314(3):257-266. PubMed ID: 33813600
[TBL] [Abstract][Full Text] [Related]
12. The Genomic Landscape of Actinic Keratosis.
Thomson J; Bewicke-Copley F; Anene CA; Gulati A; Nagano A; Purdie K; Inman GJ; Proby CM; Leigh IM; Harwood CA; Wang J
J Invest Dermatol; 2021 Jul; 141(7):1664-1674.e7. PubMed ID: 33482222
[TBL] [Abstract][Full Text] [Related]
13. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.
Ratushny V; Gober MD; Hick R; Ridky TW; Seykora JT
J Clin Invest; 2012 Feb; 122(2):464-72. PubMed ID: 22293185
[TBL] [Abstract][Full Text] [Related]
14. Identification of key genes in cutaneous squamous cell carcinoma: a transcriptome sequencing and bioinformatics profiling study.
Zou DD; Xu D; Deng YY; Wu WJ; Zhang J; Huang L; He L
Ann Transl Med; 2021 Oct; 9(19):1497. PubMed ID: 34805359
[TBL] [Abstract][Full Text] [Related]
15. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
[TBL] [Abstract][Full Text] [Related]
16. Genomic Progression of Precancerous Actinic Keratosis to Squamous Cell Carcinoma.
Kim YS; Shin S; Jung SH; Park YM; Park GS; Lee SH; Chung YJ
J Invest Dermatol; 2022 Mar; 142(3 Pt A):528-538.e8. PubMed ID: 34480890
[TBL] [Abstract][Full Text] [Related]
17. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
[TBL] [Abstract][Full Text] [Related]
18. Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.
Xu G; Fang J; Xu J; Shen Z; Huang C; Jiang Y
Bioengineered; 2021 Dec; 12(2):9930-9938. PubMed ID: 34874800
[TBL] [Abstract][Full Text] [Related]
19. Dermatopathologic features of cutaneous squamous cell carcinoma and actinic keratosis: Consensus criteria and proposed reporting guidelines.
Christensen RE; Elston DM; Worley B; Dirr MA; Anvery N; Kang BY; Bahrami S; Brodell RT; Cerroni L; Elston C; Ferringer T; Hurley MY; Garton K; Lee JSS; Liu Y; Maize JC; McNiff JM; Rapini RP; Sangueza OP; Shea CR; Zhou C; Alam M
J Am Acad Dermatol; 2023 Jun; 88(6):1317-1325. PubMed ID: 36841336
[TBL] [Abstract][Full Text] [Related]
20. Single-cell RNA-seq reveals actinic keratosis-specific keratinocyte subgroups and their crosstalk with secretory-papillary fibroblasts.
Li J; Xia Y; Kong S; Yang K; Chen H; Zhang Y; Liu D; Chen L; Sun X
J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2273-2283. PubMed ID: 37357444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
